Atsushi Yawata
-
- Cell death mechanisms and regulation 2
-
- Gastrointestinal Tumor Research and Treatment 2
-
- Chronic Lymphocytic Leukemia Research 2
-
- Ovarian cancer diagnosis and treatment 2
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 2
- Esophageal and GI Pathology 2
-
- Inflammatory Myopathies and Dermatomyositis 2
-
- Gastric Cancer Management and Outcomes 2
- Co-authors
- Kohzoh ImaiJohn C. ReedMasaaki AdachiShinichi TakayamaYuji HinodaYasuyoshi NaishiroHiroyuki OkudaMasato Hareyama
- Partner nations
- JapanUnited States
In The Last Decade
Atsushi Yawata
20 papers receiving 564 citations
Peers
Comparison fields: 5 of 75
- Cancer Research 85
- Molecular Biology 353
- Immunology and Allergy 30
- Oncology 131
- Gastroenterology 18
Countries citing papers authored by Atsushi Yawata
This map shows the geographic impact of Atsushi Yawata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Atsushi Yawata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Atsushi Yawata more than expected).
Fields of papers citing papers by Atsushi Yawata
This network shows the impact of papers produced by Atsushi Yawata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Atsushi Yawata. The network helps show where Atsushi Yawata may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Atsushi Yawata, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 5 | |
| 2 | 2022 | 7 | |
| 3 | 2022 | 0 | |
| 4 | 2022 | 0 | |
| 5 | 2019 | 2 | |
| 6 | 2016 | 9 | |
| 7 | 2014 | 22 | |
| 8 | Irinotecan as the key chemotherapeutic agent in second-line treatment of metastatic gastric cancer after failure of first-line S-1 or S-1/CDDP therapy. | 2011 | 3 |
| 9 | 2005 | 52 | |
| 10 | 2004 | 5 | |
| 11 | 2002 | 91 | |
| 12 | 1999 | 50 | |
| 13 | 1998 | 135 | |
| 14 | 1998 | 13 | |
| 15 | 1997 | 113 | |
| 16 | 1995 | 1 | |
| 17 | 1994 | 28 | |
| 18 | 1993 | 19 | |
| 19 | [A case of hyperthyroidism appeared during interferon treatment for chronic hepatitis C]. | 1993 | 2 |
| 20 | 1992 | 12 |
About Atsushi Yawata
Atsushi Yawata is a scholar working on Gastroenterology, Genetics and Hepatology, having authored 22 papers that have together received 572 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (2 papers), Ovarian cancer diagnosis and treatment (2 papers), Cell death mechanisms and regulation (2 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers), Esophageal and GI Pathology (2 papers), Gastrointestinal Tumor Research and Treatment (2 papers), Inflammatory Myopathies and Dermatomyositis (2 papers) and Gastric Cancer Management and Outcomes (2 papers). The work is most often cited by research in Cancer Research (85 citations), Molecular Biology (353 citations) and Immunology and Allergy (30 citations). Atsushi Yawata has collaborated with scholars based in Japan and United States. Frequent co-authors include Kohzoh Imai, John C. Reed, Masaaki Adachi, Shinichi Takayama, Yuji Hinoda, Yasuyoshi Naishiro, Hiroyuki Okuda, Masato Hareyama, Hiroaki Okuda and Akinori Takaoka. Their work appears in journals such as Oncogene, British Journal of Cancer and Endoscopy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.